Rotarix: development of a live attenuated monovalent human rotavirus vaccine.
Bernstein
David I
DI
Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center, OH 45229, USA. davis.bernstein@cchmc.org
Ward
Richard L
RL
D002648:Child; D002986:Clinical Trials as Topic; D017277:Drug Approval; D004341:Drug Evaluation; D004502:Education, Medical, Continuing; D006801:Humans; D007443:Intussusception / Q000209:etiology; D010372:Pediatrics / Q000193:education; D012400:Rotavirus Infections / Q000517:prevention & control*; D022243:Rotavirus Vaccines / Q000009:adverse effects; D016896:Treatment Outcome; D014613:Vaccines, Attenuated
D022243:Rotavirus Vaccines; D014613:Vaccines, Attenuated